Infliximab biosimilars INFLECTRA and REMSIMA

Original and biosimilar: no difference?

IMPROVE-IT trial with ezetimibe (EZETROL, in INEGY and others)

On the frequency of INR measurements during treatment with phenprocoumon

Rota virus vaccination: recommendation versus actual medical care situation

Ketoacidosis with SGLT-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin)

Agranulocytosis with febuxostat (ADENURIC)

Adverse drug reactions missing from product information: gliptins and bullous pemphigoid, isotretinoin and anal fissure, terbinafine and impotence

Misconduct at study sites - most often not reported in publications

© arznei-telegramm 6/2015